Browse by Poster Title

• M
• P-432
  Machine Learning Applied to SEER Data for Prediction of Breast Cancer Specific Survival
  Favorite
• P-353
  Matching Study Design to Prescribing Intention: The Prevalent New User Design in Opioid Research
  Favorite
• P-528
  Measuring the Impact of Marketing Authorisation Withdrawal and Revocation on Public Health in France, Germany and UK
  Favorite
• P-597
  Medical Cannabis Authorization and Drugs and Other Substances Use Disorders: longitudinal Cohort Study
  Favorite
• P-442
  Medication Error Concept and Reporting Practices in Saudi Arabia: A Nationwide Study Among Healthcare Professionals
  Favorite
• P-344
  Medication Regimen Complexity Among Older Adults Admitted to Home Hospice
  Favorite
• P-397
  Medicines Use by Professors at a Brazilian Public University During the covid-19 Pandemic: Findings and Implications
  Favorite
• P-564
  Melatonin Use Among Children, Adolescents, and Young Adults. a Danish Nationwide Drug Utilization Study
  Favorite
• P-103
  Methodologic Challenges and Considerations for the Collection of Dietary Intake Data in Real-world Populations
  Favorite
• P-341
  Methodological Considerations Related to the Use of Primary and Secondary Care Data in Identifying a Cohort of Moderate to Severe Psoriasis Patients in the UK
  Favorite
• P-339
  Methods and Practical Considerations in Use of an External Control to Assess Potential Drug Risk
  Favorite
• P-109
  Misuse of Antimicrobials in the Rural Population of a District in South India
  Favorite
• P-576
  Modeling Drug Treatment Effects on Breast Cancer in the Setting of Differential Screening
  Favorite
• P-248
  Modeling Parasite Clearance Curves in a Cohort to Compare Quinine and Artesunate for the Treatment of Pediatric Cerebral Malaria
  Favorite
• P-234
  Molecular Epidemiology Study of Interferon Gamma (IFN-γ) Expression in Urothelial Bladder Cancer (UBC)
  Favorite
• P-360
  Monitoring of Adverse Drug Reaction-related Parameters in Children, Youth and Young Adults Prescribed Antipsychotic Drugs by General Practitioners
  Favorite
• P-061
  Montelukast and Nightmare – Further Characterisation Using Data from Vigibase
  Favorite
• P-062
  Motives to Report Adverse Drug Reactions to the National Agency: A Survey Study Among Healthcare Professionals and Patients in Croatia, the Netherlands, and the UK
  Favorite
• P-005
  Multimorbidity Measures from Health Administrative Data: A Systematic Review
  Favorite
• P-525
  Mycophenolate and Azathioprine Are Associated with Risk of Hospitalized Viral Respiratory Infection in Rheumatoid Arthritis and Systemic Lupus
  Favorite